1. Zhai, Fengguang, Li, Yuxuan, Luo, Xia, Jin, Xiaofeng, Ye, Meng. 2024. NOLC1 was identified as a tumor suppressor gene in thyroid cancer and correlated with prognosis by bioinformatics. In American journal of cancer research, 14, 2055-2071. doi:10.62347/IYVV7581. https://pubmed.ncbi.nlm.nih.gov/38859850/
2. Sun, Zhiwei, Zhang, Qianshi, Lv, Jinjuan, Zuo, Yun-Fei, Ren, Shuang-Yi. 2023. High expression of NOLC1 as an independent prognostic factor for survival in patients with colorectal cancer. In Journal of cancer research and clinical oncology, 149, 15697-15712. doi:10.1007/s00432-023-05297-7. https://pubmed.ncbi.nlm.nih.gov/37670166/
3. Gil Rosas, Mauco, Centola, Cielo, Torres, Mercedes, Armas, Pablo, Coux, Gabriela. 2024. The transcription of the main gene associated with Treacher-Collins syndrome (TCOF1) is regulated by G-quadruplexes and cellular nucleic acid binding protein (CNBP). In Scientific reports, 14, 7472. doi:10.1038/s41598-024-58255-9. https://pubmed.ncbi.nlm.nih.gov/38553547/
4. Yuan, Fuwen, Zhang, Yu, Ma, Liwei, Li, Guodong, Tong, Tanjun. 2017. Enhanced NOLC1 promotes cell senescence and represses hepatocellular carcinoma cell proliferation by disturbing the organization of nucleolus. In Aging cell, 16, 726-737. doi:10.1111/acel.12602. https://pubmed.ncbi.nlm.nih.gov/28493459/
5. Hwang, Yu-Chyi, Lu, Tung-Ying, Huang, Dah-Yeou, Wu, Han-Chung, Lin, Chin-Tarng. 2009. NOLC1, an enhancer of nasopharyngeal carcinoma progression, is essential for TP53 to regulate MDM2 expression. In The American journal of pathology, 175, 342-54. doi:10.2353/ajpath.2009.080931. https://pubmed.ncbi.nlm.nih.gov/19541936/
智鼠故事 
